VivoSphere Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed
  • (Upcoming)

  • Latest Deal Amount
  • $1M

  • Investors
  • 11

VivoSphere General Information

Description

Developer of a three-dimensional cell culture platform designed to improve drug discovery and toxicity testing. The company offers physiologically relevant cell culture models, replicated tissue microenvironments, and reproducible, scalable screening capabilities, enabling pharmaceutical companies and biomedical researchers to generate more translatable preclinical research results, especially in oncology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Pending Transaction (VC)
Corporate Office
  • 540 Devall Drive
  • Suite 101-1A02-2
  • Auburn, AL 36832
  • United States
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Corporate Office
  • 540 Devall Drive
  • Suite 101-1A02-2
  • Auburn, AL 36832
  • United States

VivoSphere Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VivoSphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Seed Round $1M Upcoming Generating Revenue
13. Grant 01-Aug-2026 Completed Generating Revenue
12. Grant 01-Aug-2026 Completed Generating Revenue
11. Accelerator/Incubator 05-Jun-2026 Completed Generating Revenue
10. Accelerator/Incubator 19-May-2026 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
8. Grant 05-Sep-2025 Completed Generating Revenue
7. Grant 01-May-2025 Completed Generating Revenue
6. Grant 25-Mar-2025 $100K Completed Generating Revenue
5. Grant 01-Aug-2024 $100K Completed Generating Revenue
To view VivoSphere’s complete valuation and funding history, request access »

VivoSphere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VivoSphere Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Business Connect Corporation
gBETA Accelerator/Incubator
Hatch Fairhope Accelerator/Incubator
US National Science Foundation Accelerator/Incubator
Opportunity Alabama Real Estate
You’re viewing 5 of 11 investors. Get the full list »

VivoSphere FAQs

  • When was VivoSphere founded?

    VivoSphere was founded in 2022.

  • Where is VivoSphere headquartered?

    VivoSphere is headquartered in Auburn, AL.

  • What is the size of VivoSphere?

    VivoSphere has 7 total employees.

  • What industry is VivoSphere in?

    VivoSphere’s primary industry is Drug Discovery.

  • Is VivoSphere a private or public company?

    VivoSphere is a Private company.

  • What is VivoSphere’s current revenue?

    The current revenue for VivoSphere is .

  • How much funding has VivoSphere raised over time?

    VivoSphere has raised $100K.

  • Who are VivoSphere’s investors?

    Innovate UK Business Connect, gBETA, Hatch Fairhope, US National Science Foundation, and Opportunity Alabama are 5 of 11 investors who have invested in VivoSphere.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process